Results 91 to 100 of about 38,243 (258)

Virus de la hepatitis C: Avances en el tratamiento

open access: yes, 2022
La infección causada por el virus de la hepatitis C supone un problema de salud general, ya que la prevalencia global de esta enfermedad aún se considera elevada y supone al año unos 250.000 fallecimientos. Esta enfermedad puede manifestarse de manera aguda o de manera crónica llegando a situaciones graves como hipertensión portal, cirrosis, carcinoma ...
openaire   +2 more sources

Evolución terapéutica de la hepatitis crónica por virus C

open access: yesRevista Cubana de Medicina, 2018
RESUMEN Escasas áreas geográficas escapan a la pandemia que representa la infección viral por virus C. Los porcentajes de evolución a la cronicidad son altos: entre 20-30 % desarrollan cirrosis hepática y sus complicaciones dentro de 30 años. Se revisa el camino recorrido en la práctica asistencial hasta llegar a la era de los antivirales de acción ...
Pedro E. Velbes Marquetti   +2 more
openaire   +1 more source

Chronic HBV Infection Disrupts CCL5‐Secreting cNK Cells and Attenuates Liver Accumulation and Activation of DCs and HBV‐Specific T Cells

open access: yesAdvanced Science, EarlyView.
ADORA2A activation suppresses NFκB‐dependent CCL5 production in cNK cells during chronic HBV infection, disrupting intrahepatic DC recruitment and HBV‐specific CD8+ T‐cell differentiation and function. Targeting the ADORA2A/NFκB/CCL5 axis restores antiviral immunity and facilitates HBV clearance.
Ailu Yang   +9 more
wiley   +1 more source

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran   +17 more
wiley   +1 more source

Triple terapia en el virus de la hepatitis C [PDF]

open access: yesRevista Española de Enfermedades Digestivas, 2013
Fernández Castroagudín,Javier   +1 more
openaire   +4 more sources

Artículo de retractación: CARACTERIZACIÓN DE LA COINFECCIÓN DE HEPATITIS C EN PERSONAS CON VIRUS DE INMUNODEFICIENCIA HUMANA. Medicentro Electrónica. 2011;15(1):19-25.

open access: yesMedicentro, 2012
Las grandes epidemias del virus de inmunodeficiencia humana y del virus de hepatitis C coinciden temporalmente en la historia reciente de la humanidad, por lo que fue propósito de esta investigación caracterizar la coinfección entre ambos virus en el ...
María de Lourdes Sánchez Álvarez   +4 more
doaj  

Hypothalamic Control of Liver Health and Disease: From Circuits to Pathophysiology and Therapies

open access: yesAdvanced Science, EarlyView.
This review delineates the hypothalamic circuits that control liver homeostasis via autonomic and neuroendocrine pathways. Dysregulation of this hypothalamus–liver axis drives disease progression across a spectrum including steatotic liver disease, liver inflammation and injury, fibrosis, cirrhosis, and hepatocellular carcinoma.
Qin Tang   +7 more
wiley   +1 more source

Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study

open access: yesHepatology, EarlyView., 2022
Graphical abstract summarizing the study design, main results and key findings Abstract Background and Aims Fatty liver disease (FLD) has been associated with excess mortality. Screening for hepatic steatosis (HS) in patients with metabolic dysfunction is therefore recommended by several guidelines, despite a paucity of evidence on the clinical ...
Laurens A. van Kleef   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy